Drug-induced liver injury (DILI) is a significant concern in clinical practice, arising from medications, herbs, and dietary ...
Medical Dialogues presents a rare disease series, delving into the realm of uncommon medical conditions. Rare diseases are ...
Research published in JAMA Internal Medicine reveals statins may reduce liver cancer risk by 33% and liver complications by ...
Health on MSN1d
What Is the Difference Between MAFLD and MASH?Medically reviewed by Jay N. Yepuri, MD Metabolic dysfunction-associated fatty liver disease (MAFLD) occurs when excess fat builds up in the liver. MAFLD can progress to metabolic ...
Each April, the United States recognizes National Donate Life Month, bringing attention to organ, eye, bone marrow and tissue ...
A deficiency may lead to cellular damage that contributes to fatty liver disease. While taking glutathione supplements ... long-term use of zinc supplements as a possible way to prevent hepatocellular ...
o Influence of gut microbiota in the link between dysbiosis and liver-related diseases like cirrhosis and hepatocellular carcinoma. Important note: All contributions to this Research Topic must be ...
Objective To evaluate the association between inflammation-related markers, modified Glasgow Prognostic Score (mGPS) and Glasgow Prognostic Score (GPS), and survival outcome and recurrence risk in ...
Statin users had a significantly lower 10-year cumulative incidence of hepatocellular carcinoma and hepatic decompensation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback